| Application no. and date | 21197291.4 (espacenet) (Federated) (European Patent Register), 20200807 | | Patent/reg. no. and date | DK/EP 3984538, 20251105 | | Publication date | 20220420 | | Priority no. and date | US 201962883756 P, 20190807, US 202062986297 P, 20200306 | | EP pub. no. and date |
EP 3984538 20220420 | | Effective date | | | Applicant/owner | Amicus Therapeutics, Inc., 3675 Market Street
Philadelphia, PA 19104, US | | Applicant ref. no. | 2042689 | | Inventor | BENJAMIN, Elfrida,
Philadelphia, PA 19104, US,
WU, Xiaoyang,
Philadelphia, PA 19104, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 31/445 (2006.01) , A61P 3/00 (2006.01) | | Title | MIGALASTAT TIL ANVENDELSE TIL BEHANDLING AF FABRYS SYGDOM HOS PATIENTER MED EN MUTATION I GLA-GENET | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
